Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

Sources said the offer price was set at ₹1,625 per share, a 4.9% discount to its last closing price. The total deal size was ...

The pharmaceutical and cosmetics industries have gone to the EU's court to challenge a directive that requires them to ...

Pharmaceutical warehousing is not just about storing products; it’s a critical part of the supply chain that ensures the ...

Armas Pharmaceuticals, a leading provider of high-quality pharmaceutical products, is pleased to announce the reintroduction of Lidocaine Jelly 2% 30mL to the U.S. market. This key product has been ...

Warns that Indian pharmaceutical products could become more expensive in the US, reducing their competitiveness in one of the ...

Global investment firm KKR has divested a 5.8% stake in JB Chemicals & Pharmaceuticals for Rs 1,460 crore through open market ...

Hetero Group founder, B Parthasaradhi Reddy, warns of potential US reciprocal tariffs on Indian pharmaceuticals, which could ...

Meanwhile, the spirits industry – Irish whiskey, cream liqueurs and gins – were shook by threats from Trump of a 200 per cent ...

Shares of JB Chemicals and Pharmaceuticals fell over 7% after KKR’s block deal, offloading a 5.78% stake. Despite a robust ...

Teasing tariffs on pharmaceuticals, US President Donald Trump said a lot are made in Ireland, but added that "we love Ireland ...

After threatening to impose “25% or higher” tariffs on foreign-made pharmaceuticals along with automobiles and semiconductors ...